Inventor
Hong Shen
Inventor
Plainsboro, NJ, US
Overview
Patents· 75 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07DHeterocyclic compounds20%
G06TImage data processing or generation, in general17%
A61KPreparations for medical, dental or toiletry purposes16%
G06VImage or video recognition or understanding4%
A61BDiagnosis3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
G06FElectric digital data processing2%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
A01PBiocidal, pest repellant, pest attractant or plant growth regulatory activity of chemical compounds or preparations1%
PatentTitleYear
10,781,206Tetrahydropyrazolopyridine compounds for the treatment of infectious diseases202010,683,299Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseases202010,662,203Pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection202010,653,980Connection-free filter capsule apparatus202010,645,927Antimicrobial wipe202010,611,748Xanthone derivatives for the treatment of hepatitis B virus disease202010,596,173Combination therapy of an HBV capsid assembly inhibitor and an interferon202010,428,0696-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection201910,350,522Truncated filter capsule201910,264,788Antimicrobial wipe201910,081,6276-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection201810,030,047Peptide macrocycles against acinetobacter baumannii20189,946,712Techniques for user identification of and translation of media20189,890,167'Pyrazine compounds for the treatment of infectious diseases'20189,840,501'Morpholin-pyridine derivatives'20179,790,230'2-oxa-5-azabicyclo[2.2.1]heptan-3-yl derivatives'20179,758,530'6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection'20179,706,548'Joint transmit and receive procedure'20179,663,530'5-oxa-2-azabicyclo[2.2.2]OCTAN-4-yl and 5-oxa-2-azabicyclo[2.2.1]heptan-4-yl derivatives'20179,505,730'Mineralocorticoid receptor antagonists'20169,487,506'Mineralocorticoid receptor antagonists'20169,447,086'6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection'20169,403,807'Mineralocorticoid receptor antagonists'20169,373,181'System and method for enhanced viewing of rib metastasis'20169,284,301'Soluble guanylate cyclase activators'20169,266,904'6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection'20169,260,439'Dihydropyrrolopyrimidine derivatives'20169,233,978'6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection'20169,193,717'Mineralocorticoid receptor antagonists'20159,085,568'Mineralocorticoid receptor antagonists'20158,933,113'Mineralocorticoid receptor antagonists'20158,916,593'Alkoxy-substituted 2-aminopyridines as ALK inhibitors'20148,785,632'Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors'20148,785,634'Spiropiperidine prolylcarboxypeptidase inhibitors'20148,737,699'Combinational computer aided diagnosis'20148,637,677'Organic dicarboxylic acids, salts and preparation method thereof'20148,455,520'Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment'20138,423,124'Method and system for spine visualization in 3D medical images'20138,224,057'Method and system for nodule feature extraction using background contextual information in chest x-ray images'20128,170,330'Machine learning for tissue labeling segmentation'20128,168,649'Niacin receptor agonists, compositions containing such compounds and methods of treatment'20128,165,376'System and method for automatic detection of rib metastasis in computed tomography volume'20128,165,375'Method and system for registering CT data sets'20128,106,197'Aminoheteroaryl compounds as protein kinase inhibitors'20128,107,699'Feature processing for lung nodules in computer assisted diagnosis'20128,103,077'Method and system for locating opaque regions in chest X-ray radiographs'20128,073,232'Method and system for diaphragm segmentation in chest X-ray radiographs'20118,073,214'Computer aided lesion assessment in dynamic contrast enhanced breast MRI images'20117,949,171'System and method for tracing rib posterior in chest CT volumes'20117,858,643'Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors'20107,764,816'Method for analyzing medical image data'20107,756,316'Method and system for automatic lung segmentation'20107,732,604'Triazolopyrazine derivatives'20107,724,929'System and method for myocardium segmentation in realtime cardiac MR data'20107,702,153'Systems and methods for segmenting object of interest from medical image'20107,689,265'System and method for the joint evaluation of multi phase MR marrow images'20107,672,493'Method for analyzing medical image data using level set'20107,672,492'Method of incorporating prior knowledge in level set segmentation of 3D complex structures'20107,627,159'2D visualization for rib analysis'20097,620,226'Semi-local active contour for a faint region detection in knee CT images'20097,602,965'Object detection using cross-section analysis'20097,555,152'System and method for detecting ground glass nodules in medical images'20097,480,401'Method for local surface smoothing with application to chest wall nodule segmentation in lung CT data'20097,471,815'Candidate generation for lung nodule detection'20087,397,475'Interactive atlas extracted from volume data'20087,379,576'Method and system for patient identification in 3D digital medical images'20087,369,693'Thoracic cage coordinate system for recording pathologies in lung CT volume data'20087,301,535'3D summary display for reporting of organ tumors'20077,296,239'System GUI for identification and synchronized display of object-correspondence in CT volume image sets'20077,230,098'Aminoheteroaryl compounds as protein kinase inhibitors'20077,030,097'Controlled nucleic acid delivery systems'20066,932,611'Conducting remote instructor-controlled experimentation'20056,861,418'4-aryl substituted indolinones'20056,738,063'Object-correspondence identification without full volume registration'20046,677,368'4-aryl substituted indolinones'2004Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004–2016Based in Plainsboro, NJ, US· patent location history
2007–2014Patents assigned to SIEMENS MEDICAL SOLUTIONS (19)· patent assignee history
2007–2016Based in San Diego, CA, US· patent location history
2008–2009Based in Princeton, NJ, US· patent location history
2011–2016Patents assigned to SHEN HONG (23)· patent assignee history
2011–2013Patents assigned to SIEMENS AG (6)· patent assignee history
2012–2016Based in West Windsor, NJ, US· patent location history
2013–2016Patents assigned to MERCK SHARP & DOHME (9)· patent assignee history
2016–2020Patents assigned to HOFFMANN LA ROCHE (16)· patent assignee history
2016–2020Based in Shanghai, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SHEN HONGself | 23 | 2011–2016 |
| SIEMENS MEDICAL SOLUTIONS | 19 | 2007–2014 |
| HOFFMANN LA ROCHE | 16 | 2016–2020 |
| MERCK SHARP & DOHME | 9 | 2013–2016 |
| SIEMENS AG | 6 | 2011–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Plainsboro, New Jersey, US | 28 | 2004–2016 |
| Shanghai, CN | 17 | 2016–2020 |
| San Diego, California, US | 7 | 2007–2016 |
| West Windsor, New Jersey, US | 6 | 2012–2016 |
| Princeton, New Jersey, US | 4 | 2008–2009 |